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Abstract
Background: Type IV secretion (T4S) systems are involved in secretion of virulence factors such as toxins or
transforming molecules, or bacterial conjugation. T4S systems are composed of 12 proteins named VirB1-B11 and
VirD4. Among them, three ATPases are involved in the assembly of the T4S system and/or provide energy for
substrate transfer, VirB4, VirB11 and VirD4. The X-ray crystal structures of VirB11 and VirD4 have already been solved
but VirB4 has proven to be reluctant to any structural investigation so far.
Results: Here, we have used small-angle X-ray scattering to obtain the first structural models for the membrane-
extracted, dimeric form of the TraB protein, the VirB4 homolog encoded by the E. coli pKM101 plasmid, and for the
monomeric soluble form of the LvhB4 protein, the VirB4 homolog of the T4S system encoded by the Legionella
pneumophila lvh operon. We have obtained the low resolution structures of the full-length TraB and of its N- and
C-terminal halves. From these SAXS models, we derive the internal organisation of TraB. We also show that the two
TraB N- and C-terminal domains are independently involved in the dimerisation of the full-length protein.
Conclusions: These models provide the first structural insights into the architecture of VirB4 proteins. In particular, our
results highlight the modular arrangement and functional relevance of the dimeric-membrane-bound form of TraB.
Background
Type IV secretion (T4S) systems are one of six secretion
systems used to transport effector proteins or DNAs
through the cell membrane of Gram-negative bacteria.
These six secretions systems can be categorised into two
classes. The first class of secretion systems mediates sub-
strate transfer from the cytosol to the extracellular milieu
in one step: substrates captured from the cytosol are
released extracellularly without the need for a periplas-
mic intermediate [1]. The second class encompasses a
range of specialised outer membrane (OM) secretion sys-
tems: the substrate is first transported through the inner
membrane (IM) to the periplasm via the general SecA-
BYEG secretion machinery and then uses specialised OM
systems for extracellular release [2,3]. T4S systems
belong to the first class.
T4S systems export proteins and DNA-protein
complexes and fulfil a wide variety of functions, such as
i- the conjugative transfer of plasmids and other mobile
DNA elements to bacterial recipient cells, ii- the direct
uptake of DNA from the extracellular milieu or iii- the
delivery of protein or DNA substrates to eukaryotic tar-
get cells [4,5]. T4S systems are used by several plant
and human pathogens for virulence. Such bacterial
pathogens include Agrobacterium tumefaciens, the cau-
sative agent of crown gall disease in plants, Bordetella
pertussis, the agent responsible for whooping cough in
children, and Helicobacter pylori, responsible for gastric
ulcers and stomach cancer [6-9]. In addition, there are
intracellular bacterial pathogens utilising T4S systems
for virulence, such as Brucella suis, the causative agent
of brucellosis, and Legionella pneumophila, the causative
agent of Legionnaires’ disease [10,11].
T4S systems are generally composed of 12 protein com-
ponents forming a macromolecular assembly inserted into
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the bacterial cell envelope [5]. These proteins are named
VirB1-VirB11 and VirD4, based on the widely used
nomenclature of the model system, the A. tumefaciens
VirB/D4 T4S system. Three ATPases are key components
of the T4S system: VirD4, VirB11 and VirB4. VirB4 pro-
teins are the largest and the most evolutionarily conserved
proteins in T4S systems [12] but their function remains
unclear. Although VirB4 proteins have clearly defined
Walker A and Walker B motifs characteristic of ATPases
[13], until very recently no ATPase activity had been
demonstrated for any VirB4 homologues [13]. However,
two recent studies have shown that ATPase activities of
VirB4 proteins are crucially dependent on solution condi-
tions and on the oligomerisation state of VirB4 [14,15]. For
TrwK, the VirB4 homolog encoded by the R388 conjuga-
tive plasmid system, Rabel et al. [13] initially reported that
the protein exhibited no ATPase activity and was mono-
meric. However Arechaga et al. [14], in a subsequent study,
reported an ATPase activity of TrwK in the presence of
acetate ions, possibly due to a small proportion of an hex-
americ form of the protein. TraB, the VirB4 homolog
encoded by the pKM101 conjugative plasmid system, also
exhibits ATPase activity in the presence of acetate ions and
is primarily hexameric under these solution conditions
[15]. Interestingly, TraB partitions between the cytosol and
the inner membrane, and the membrane-extracted form
does not exhibit ATPase activity, even in the presence of
acetate ions [15]. This membrane-extracted form of TraB
was also shown to be dimeric. It was concluded that cyto-
solic TraB is in equilibrium between a dimeric form that
binds DNA and nucleotides, but is unable to hydrolyze
ATP, and an acetate-induced hexameric form able to
hydrolyse ATP. TraB purified from the membrane is in the
dimeric form, and is unable to transition to the hexameric
form even in the presence of acetate ions [15]. Interest-
ingly, A. tumefaciens VirB4 was also shown to form active
dimers in vivo [16], strongly supporting a functional role of
this dimer, besides the hexameric form.
The structure of VirB4 proteins is still unknown, as they
have resisted extensive crystallisation efforts either in the
hexameric or the dimeric form. Attempts at visualising
acetate-induced hexameric TraB by negative stained elec-
tron microscopy or small-angle X-ray scattering have
failed [15]. Recently, based on sequence similarities with
TrwB (the VirD4 homolog from the plasmid R388 conju-
gation system), the A. tumefaciens VirB4 C-terminal
domain was modelled, as an homo-hexameric ring [17]
much like VirB11 and VirD4 [18]. However no structural
experimental data has yet backed this model, most prob-
ably because it has been impossible so far to stabilise and
isolate the hexameric form of VirB4. Here we report the
low resolution structure of the membrane-extracted
dimeric form of TraB, using small-angle X-ray scattering
(SAXS). We also performed a SAXS analysis of the
N-terminal (TraBNT) and C-terminal (TraBCT) domains of
TraB, and of the full-length monomeric LvhB4, the VirB4
homolog from the L. pneumophila T4S system, which
represents the first in vitro study of a member of the
L. pneumophila lvh T4S system. Altogether, our results
provide the first insights into the architecture of the highly
conserved VirB4 family of proteins.
Results
Purification of TraB domains and LvhB4
Based on sequence homology between the C-terminal
domain of TraB and the protein TrwB, the E. coli R388-
encoded VirD4 homolog, we previously established that
TraB can be divided into two folded domains
(Figure 1A): a C-terminal domain (residues 448 to 848,
TraBCT), which is soluble, and an N-terminal domain
(residues 1-442, TraBNT), which partitions between a
soluble form in the cytosol and a membrane-bound form
[15]. These two domains are functional as they are each
able to bind DNA and ATP [15]. Full-length TraB
(TraBFL) was subsequently found to partition between a
soluble and membrane-bound form [15]. Various
transmembrane domains predictors were used to
screen the sequence of TraB (DAS, http://www.sbc.su.se/
~miklos/DAS/; HMMTOP, http://www.enzim.hu/
hmmtop/; TMPred, http://www.ch.embnet.org/software/
TMPRED_form.html; TMHMM, http://www.cbs.dtu.dk/
services/TMHMM-2.0/; and TopPred, http://mobyle.pas-
teur.fr/cgi-bin/portal.py?form=toppred). The predictions
were not fully consistent, except for one stretch that was
predicted by two out of the 5 different predictors,
between residues 254 and 271. This suggests the exis-
tence of a transmembrane (TM) segment in TraB, or of a
hydrophobic patch through which TraB might be asso-
ciated with the membrane.
For this study, TraBFL and TraBNT were both purified
from the membrane fraction, while TraBCT, which is
soluble and does not partition in the membrane, was pur-
ified from the soluble fraction. For comparison, we
cloned, expressed and purified the full-length LvhB4, the
VirB4 homolog from the L. pneumophila T4S system, for
which no predicted TM domain was found. Indeed,
LvhB4 purifies from the soluble fraction and not from
the membrane fraction, demonstrating that the protein is
not located in the membrane. All four proteins were pur-
ified to homogeneity using the same two-step purification
strategy (Figure 1B and “Materials & Methods”). In SDS-
PAGE the proteins migrate at their expected molecular
mass: 102 kDa for TraBFL, 55 kDa for TraBNT, 49 kDa for
TraBCT, and 94 kDa for LvhB4 (Figure 1B).
Size Determination of TraB domains and LvhB4
We investigated the oligomeric state of all four proteins
in the GFsol (TraBCT and LvhB4) and GF
mb (TraBNT
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and TraBFL) buffer conditions (see definition of GF
sol
and GFmb in Materials and Methods). Table 1 sum-
marizes the results obtained by Gel Filtration, Dynamic
Light Scattering and Native-Gel electrophoresis. The
calibration of the gel filtration column (see “Materials &
Methods”) allowed us to evaluate the apparent
molecular mass of the proteins according to their elu-
tion volume. TraBFL ran as a 198.1 kDa protein, TraBNT
as a 122.1 kDa protein, TraBCT as a 100 kDa protein,
and LvhB4 as a 92.7 kDa protein. By comparison with
the calculated molecular mass obtained from the amino
acid sequence, we concluded that TraBFL, TraBNT and
TraBCT were all forming dimers under the examined
buffer conditions. In contrast, LvhB4 behaved as a
monomer in the same conditions. DLS and blue-native
PAGE (BN-PAGE) confirmed these results for TraBFL
and TraBCT (Table 1). In conclusion, all TraB-derived
constructs form only dimers in solution, whereas LvhB4
forms monomers.
Overall SAXS Parameters
Small-angle X-ray scattering (SAXS) studies yield informa-
tion on the size and shape of macromolecules in solution,
and also on the oligomerisation state of macromolecules.
The overall dimensions of a protein can be evaluated by
Figure 1 Schematic representation of the domain structures of TraB. (A) N: N-terminus; C: C-terminus; TM: Putative transmembrane domain;
NBD: NTP binding domain; FL: TraB full-length (TraBFL: 1-866); NT: TraB N-terminal domain (TraBNT: 1-442); CT: TraB C-terminal domain (TraBCT:
448-848). (B) NuPAGE 4-12% showing the purified proteins after gel filtration. (Lane 1) TraBFL (102 kDa); (Lane 2) TraBNT (55 kDa); (Lane 3) TraBCT
(48.8 kDa); and (Lane 4) LvhB4 (93.8 kDa). Molecular mass markers are indicated on the left side of the gel (kDa). A transmembrane segment (TM)
in TraB is predicted, between residues 254 and 271.
Table 1 Theoretical and experimental Molecular Mass
(MM) determination
MMCalc GF calibration D.L.S BN-PAGE Oligomeric state
TraBFL 103 198 184 146 - 242 Dimer
TraBNT 55 122 ND ND Dimer
TraBCT 49 100 100 66 - 146 Dimer
LvhB4 97 93 105 ND Monomer
All MM are given in kDa. “MMCalc” is the MM calculated from the amino-acid
sequence, “GF” stands for gel filtration, “DLS” stands for Dynamic Light
Scattering, “BN-PAGE” stands for Blue Native-PAGE. The oligomeric state is
deduced from the comparison between MMCalc and the experimental MM as
determined by the other approaches. “ND” stands for non-determined.
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its radius of gyration, RG, while the molecular mass of the
scattering particle is inferred from the forward scattering
intensity, I(0), both derived from the Guinier law (see
Materials and Methods). The scattering curves of all the
constructs followed the Guinier law very well (Figure 2)
and did not display any sign of aggregation in solution.
We determined the molecular mass of each construct of
TraB from their experimental I(0) and obtained 219 kDa
for TraBFL, 106 kDa for TraBNT, and 83 kDa for TraBCT
(Table 2). After comparison with the expected molecular
mass of the monomer of each TraB-derived constructs
we concluded that all of them were dimers under the
examined solution conditions (Table 2). For TraBFL and
TraBNT, the molecular masses inferred from the forward
scattering intensity are very similar to the theoretical
molecular masses calculated from their sequence. This
strongly suggests that very few detergent molecules are
bound to the proteins, and therefore that the contribu-
tion of the detergents to the scattering intensity can be
considered as negligible. LvhB4 was confirmed to be a
monomer with a molecular mass experimentally
calculated to be 116 kDa, very close to the expected
monomer size of 97 kDa. The I(0) determination of the
molecular mass of all four proteins were consistent with
our biochemical results and confirmed their oligomeric
states. These results suggest that both the N- and C-
terminal halves of TraB participate in the dimer interface
of the full-length protein.
The radii of gyration measured on the different con-
structs are summarized in Table 2. Surprisingly, TraBFL
and TraBNT have similar radii of gyration (58.6 ± 0.6 Å
and 60.3 ± 0.7 Å respectively), in spite of the molecular
mass of TraBNT being half of that of TraBFL. In contrast,
the radii of gyration of TraBCT and LvhB4 are smaller
(41.5 ± 0.5 Å and 37.2 ± 0.6 Å respectively). Proteins of
similar radius of gyration may have very different shape
and mass depending on their structure. Thus, TraBFL
and TraBNT may have similar RG values but different
structures. According to the SAXS results, TraBCT and
consequently TraBFL are on average more compact than
TraBNT. The RG of TraBNT reflects a less compact
structure with a lower molecular mass, whereas, the RG
Figure 2 Determination of the radius of gyration RG of the TraB constructs and of LvhB4 by the Guinier approximation. The RG is
inferred from the slope of the straight line fitting Ln I(q) vs q2, for qRG < 1.0. The points of the scattering curve used for the linear fit (straight
line) are indicated by filled symbols, and the rest of the curve is represented by open symbols (TraBFL:square; TrabNT: triangle; LvhB4:circle; and
TraBCT:diamond).
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of TraBFL results from a more compact structure and
higher molecular mass, these two parameters counter-
balancing each other to yield similar RG values.
We then calculated the pair-distance distribution
function, P(r), from the SAXS curves (see “Materials &
Methods”). The P(r) functions for all four constructs
exhibited a bell-shaped curve with a slightly extended
profile for the higher distances (data not shown), indi-
cating a globular but somewhat elongated conformation.
The comparison of the values obtained for the radius of
gyration (RG) and for the maximum dimension (Dmax)
for the four proteins gives an idea of their anisotropy.
To obtain an estimation of the anisotropy of the protein,
we calculated the ratio between RG and Dmax values for
each construct. In the case of a sphere, this ratio is
equal to 0.39, as the radius of a sphere is equal to
(3/5)1/2R, where R is the radius of the sphere. Table 2
summarizes the values computed for all the constructs.
The ratio RG/Dmax is 0.30 for TraBFL, 0.30 for TraBNT,
0.31 for TraBCT and 0.32 for LvhB4, significantly differ-
ent than the value for a sphere, considering the error
bars measured on the RG and Dmax. Interestingly, despite
having different sizes, all four constructs exhibit the same
anisotropy (ratio RG/Dmax of ~0.3), indicating that the
proteins are rather anisotropic, and thus elongated.
Low Resolution Shapes from Ab Initio Modeling
The overall shapes of the four proteins were computed
from the SAXS profiles using the program GASBOR [19].
For all TraB derived constructs (TraBFL; TraBNT and
TraBCT), we used an imposed 2-fold symmetry axis
(referred as P2 in GASBOR) for generating the recon-
structed models, in agreement with the oligomerisation
state inferred from the biochemical data and from the for-
ward scattering intensity I(0). Similar shapes were also
obtained without imposing any symmetry (referred as P1
in GASBOR, data not shown). For LvhB4, no symmetry
was imposed to reconstruct the 3D-volume. Several inde-
pendent calculations provided highly reproducible results,
with very similar models, and fit to the data of similar
quality. The average shapes calculated from repeated, mul-
tiple modelling processes (data not shown) give each time
a shape similar to the best individual model, defined by
the lowest ChiExp value. Figure 3 shows that the fit to the
experimental data of these shapes for all four proteins is
very good, as confirmed by the value of ChiExp (Table 2).
The very reproducible shapes together with the very low
ChiExp, obtained when fitting the data (Table 2) give good
confidence that the inferred model is not an artifact due
to the SAXS intrinsic degeneracy and that these shapes
are reliable. We decided to use the best model for each
construct as representative of their low resolution struc-
ture in solution. Overall, the shapes of the four proteins
appear to be globular but rather elongated (Figure 4), as
expected from the RG/Dmax ratio. TraBFL presents two
symmetrical lobes with two distinctive protruding ends,
with each lobe being potentially attributable to one TraBFL
monomer in the dimeric assembly (Figure 4A). On the
other hand, the shapes of both TraBNT (Figure 4B) and
TraBCT (Figure 4C) appeared to be rather flat and elon-
gated with few protruding extensions. The symmetrical
2-fold axis separating the two monomers is however
clearly visible in the reconstructed volumes, even without
imposing any symmetry (data not shown). Interestingly,
the low-resolution structure of LvhB4 (Figure 4D) shows
an asymmetrical and compact, yet rather extended
conformation.
Superposition and comparison of the TraB derived models
TraBNT and TraBCT represent the N- and C-terminal
halves of TraBFL, respectively (see Figure 1 and “Materials
& Methods”). Thus, given that all the three TraB-derived
constructs are dimeric, the sum of the reconstructed
volumes of both TraBNT and TraBCT should give a value
similar to the volume of TraBFL. We used the program
CRYSOL [20] to evaluate the volume of the reconstructed
models (Table 2). We found that the sum of the volumes
of TraBNT and TraBCT gives a value very close to the
volume of TraBFL (represented here by the ratio of the
volumes being close to 1.0, see table 2). We then manually
Table 2 Biophysical parameters estimated by SAXS
Protein MMCalc (kDa) MMExp (kDa) O.S RG* (Å) RG ** (Å) Dmax (Å) RG**/Dmax V (Å
3) GASBOR ChiExp
TraBFL 103 219 2 58.6 ± 0.6 58.8 198 ± 2 0.30 2.4 × 10
5 1.96
TraBNT 55 106 2 60.3 ± 0.7 59.2 195 ± 5 0.30 1.3 × 10
5 1.56
TraBCT 49 83 2 41.5 ± 0.5 46.1 150 ± 5 0.31 1.1 × 10
5 0.61
LvhB4 97 116 1 37.2 ± 0.6 38.1 120 ± 5 0.32 1.1 × 105 2.01
(TraBNT+TraBCT)/TraBFL 1.01 0.86 1.0
2(LvhB4)/TraBFL 0.94 1.06 0.92
MMCalc: Theoretical molecular mass calculated from amino acid sequence. MMExp: Experimentally based molecular mass calculated from the scattering intensity
extrapolated at zero angles I(0). O.S: Oligomeric state, as determined by comparison between the MMCalc and the MMExp. RG*: Radius of gyration, estimated from
the Guinier plots. RG**: Radius of gyration, estimated using the program GNOM. V: volume of the envelope calculated by ab initio modelling. ChiExp: discrepancy
between the experimental SAXS profile and the fit for each model calculated by the program GASBOR. The ratios of the Molecular Masses and of the volumes
between different constructs are given in the last two lines.
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superimposed the shapes of TraBNT and TraBCT onto the
shape of TraBFL. Several respective orientations of TraBNT
and TraBCT were tested and for only one orientation the
TraBNT and TraBCT models fit well together into the
TraBFL model without any clash (Figure 5A). In the pro-
posed TraBFL model, the longest dimension of TraBNT
and TraBCT are 45° apart, with the longest dimension of
TraBNT coinciding with that of the TraBFL dimer. In this
model, the more compact structure of TraBCT lays onto
the more elongated structure of TraBNT (Figure 5B and
5C). Two schemes for the location of the TraB monomer
and its two domains can be inferred from these SAXS
envelopes of TraBFL and TraB fragments (Figure 5D and
5E). In one scheme (dimer 1, Figure 5D), each TraB
monomer is positioned on either side of an axis perpendi-
cular to the long axis of the TraB dimer. In the other
scheme (dimer 2, Figure 5E), each TraB monomer is posi-
tioned on each side of the long TraB dimer axis.
Comparison between TraBFL and LvhB4 and orientation
of the TraB monomers
VirB4 proteins are the most conserved components
(amino-acid sequence wise) of the T4S systems. It was
then logical to think that VirB4 proteins could have
a similar shape, albeit with different oligomeric states.
We thus hypothesised that if TraBFL and LvhB4 mono-
mers (34% identity) share a similar overall tertiary struc-
ture, the latter could help us localise TraBFL monomers in
the dimeric model. The ratio between the volumes of two
LvhB4 monomers and one dimeric TraBFL is of the same
order as the ratio of their molecular masses, with LvhB4
slightly smaller than TraBFL monomers (Table 2). There-
fore, we tried to manually fit two LvhB4 monomers into
the envelope of the TraBFL dimer. Figure 6 shows the
results obtained with two possible orientations: orientation
1 (Figure 6A and 6B) with each of the LvhB4 monomer
being on each side of an axis perpendicular to the TraBFL
dimer longest axis; and orientation 2 (Figure 6C and 6D)
with each LvhB4 monomer being on each side of the long-
est axis of the TraBFL dimer. In Figure 6B and 6D, we have
superimposed the schematic diagrams of Figure 5D and
5E, respectively. In both orientations, there remains empty
spaces in the TraBFL dimer, not filled by two LvhB4
monomers. In the case of orientation 1, this empty space
is localized in between the two monomers. This is not in
agreement with the evidence of a stable TraBFL dimer and
Figure 3 Scattering curves of the different constructs of TraB and of LvhB4. The calculated I(q) profiles (black line) of the four different
structures restored from the SAXS data are compared with the measured SAXS data (red circles) for TraBFL (A); TraBNT (B); TraBCT (C) and LvhB4
(D). “AU” stands for “Arbitrary Units”.
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with the fact that both the N- and C-terminal domains
have been also isolated as dimers. Conversely, in the case
of orientation 2, this empty space is localized at the
N-terminal ends of LvhB4. This is consistent with the
shorter N-terminal domain of LvhB4 compared to TraB
and subsequently with the smaller volume of the LvhB4
model compared to the corresponding volume of the
TraBFL monomer (taken as half of the observed TraBFL
dimer volume; Table 2). In addition, the contact areas
between the two N-terminal domains and the two C-term-
inal domains are larger, allowing formation of stable
TraBFL, TraBNT and TraBCT dimers (see cartoons in Fig-
ure 6D). In conclusion, we favor orientation 2 as best
describing the possible arrangement of the TraBFL mono-
mers into the dimeric model.
Comparison between TraBCT model and the
homology-based structure of At-VirB4
As mentioned previously, Middleton et al. [17] have
modeled the structure of the C-terminal domain of the
A. tumefaciens VirB4 (At-VirB4-Cter) based on the
sequence homology with the VirD4 protein TrwB from
the R388 conjugation machinery. Since TraB and
At-VirB4 are highly homologous, we used this At-VirB4-
Cter model and tried to fit two of them into the TraBCT
dimeric shape. Indeed, as shown in Figure 7 (panel A),
we could manually fit the two At-VirB4-Cter models
into the TraBCT dimer volume. The two At-VirB4-Cter
subunits are arranged according to the two-fold symme-
try axis of the TraBCT dimer. As shown in Figure 7A,
this docking identifies the C-terminal end of TraB as
participating in the dimer interface. Similarly, we super-
imposed the At-VirB4-Cter model with the SAXS envel-
ope of LvhB4 (Figure 7, panel B). From this comparison
we propose that the C-terminal domain of LvhB4 is pos-
sibly localised at the wider end of the curved shape,
opposite to the narrow end. The empty space in the
superimposition would consequently be the N-terminal
domain of LvhB4. This orientation fits well with the
models presented in Figure 6C and 6D, showing the
Figure 4 Ab initio models of the different constructs of TraB and of LvhB4. Two orientations, rotated along the long axis, of the best
models generated by the program GASBOR of TraBFL (A); TraBNT (B); TraBCT (C) and LvhB4 (D). All TraB models (FL; NT; CT) were generated with
an imposed P2 symmetry. The black cross and the dashed-line indicate the P2 symmetry axis between the two monomers in the dimeric model.
The double arrow-head dotted-line indicates the maximum dimension (Dmax) of each model.
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superimposition of two LvhB4 monomers into the
TraBFL dimeric model.
Discussion
The SAXS experiments reported here confirm that TraB
and its N- and C-terminal domains are dimeric in the
acetate-free solution conditions under which the experi-
ments were conducted, indicating that both domains par-
ticipate in the dimer interface. The structures of the two
domains revealed elongated shapes, which in the
full-length protein come together at a 45° angle. The
superposition of the LvhB4 structure could resolve the
ambiguity as to where the TraB monomer lies, and
favored dimer 2 (Figure 5E), where the monomer would
extend along the long axis of the dimer structure. Indeed,
in the superimpositions of the two LvhB4 monomers
onto the TraBFL dimer structure presented in Figure 6B
and 6D, only the one aligning the LvhB4 monomers
along the long axis of the TraB structure gives rise to an
extended dimer interface. The configuration in Figure 5D
(Dimer 1) would be expected to yield a less stable dimer
than is observed. Also, a more extended conformation of
TraB is consistent with our observation that TraB is sus-
ceptible to proteolysis and that limited proteolysis of
TraB very rapidly yields TraBCT (data not shown).
VirB4 is a family of very conserved proteins that are
essential components of T4S systems [12] However,
recent biochemical studies have revealed that this family
of proteins is more diverse than originally expected [13].
For example, their oligomerisation state appears differ-
ent depending on the system under investigation and
the conditions under which they are studied. TraB has
Figure 5 Assembly of TraB-domain SAXS models, reconstituted with the program GASBOR. (A) The TraBNT (blue) and TraBCT (red) models
are superimposed onto the TraBFL model (transparent yellow). (B) The TraBNT model is superimposed onto the TraBFL model. (C) The TraBCT
model is superimposed onto the TraBFL model. (D and E) Cartoons representing the domain organisation of TraB deduced from the SAXS
models. Two possibilities for the TraBFL monomer are shown, with dimer 1 (D) and dimer 2 (E). The inset shows the TraBFL monomer. In the
dimer, one monomer is represented in plain lines without transparency, the other monomer is represented in dotted-lines and transparency. The
black cross and the dashed-line both indicate the P2 symmetry axis of the dimeric models. The SAXS models are shown in two orientations,
with a 90° degrees angle rotation along the long axis.
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been shown to be in equilibrium between two oligo-
meric states, dimer and hexamer, dependent on the
solution conditions, namely the presence or absence of
acetate ion [15]. TrwK appears to transition between a
major monomeric form and minor hexameric form [14].
The VirB4 homolog encoded by the cag pathogenicity
island in H. pylori appears to be monomeric [13] and
we show here that, under the solution conditions exam-
ined, the VirB4 homolog from L. pneumophila LvhB4 is
monomeric. Hexamer formation appears to be required
for ATP-hydrolyzing activity: indeed only hexameric
forms of VirB4 homologs have been shown to exhibit
ATPase activity [14,15]. So far, only sparse information
has been gathered about the function of the dimeric
TraB. We recently reported its DNA and nucleotide
binding activities [15], while A. tumefaciens VirB4 was
shown to direct dimer formation when fused to the
N-terminal portion of the cI repressor protein [16]. The
different subcellular localisation of TraB together with
the recent characterization of a degenerated nucleotide
binding site in its N-terminal domain [15] are features
also observed in the SecA translocase, perhaps suggest-
ing an evolutionary relationship between the two protein
families [21,22]. Finally, TraB in the context of the
entire T4S machinery might interact with different part-
ners. Indeed, its close association with TraA (the VirB3
homolog encoded by the pKM101 plasmid) or its docu-
mented protein-protein interactions with other T4S sys-
tem components could induce the conformational
changes necessary to reshape the active site or radically
change its cell environment more specifically, in order
to stabilise an active dimeric membrane-bound form.
Conclusions
The work presented here provides the first structural
glimpse of a protein which is crucial to type IV secre-
tion but has until now resisted X-ray crystallography or
EM structural characterisation. It uncovers a modular
structure that comes together in an extended dimer
interface where the domains appear to “hug” each other.
The dimers corresponding to each domain could easily
be put together in the envelope of the full length protein
Figure 6 Comparison between TraBFL model and LvhB4 model reconstituted from SAXS data. Two possible orientations of two LvhB4
monomers into the TraBFL model, with (A, ORIENTATION 1)) the two LvhB4 monomers are aligned along the shortest axis of the TraBFL model,
or (C, ORIENTATION 2) the two LvhB4 monomers (in light- and dark-green) are aligned along the longest axis of the TraBFL model (in transparent
yellow). (B): same as A but for the cartoon representation of TraB in Figure 5D being superimposed. (D): same as C but for the cartoon
representation of TraB in Figure 5E being superimposed. Each panel shows two perpendicular views of the model. The two LvhB4 monomers
were manually fitted into the TraBFL model. The black cross and the dashed-line both indicate the P2 symmetry axis of the dimeric models.
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and the structural model for LvhB4 helps suggest a
potential model for the full-length protein. Intriguingly,
the predicted TM segment locates within the N-terminal
domain, not at the boundaries of the domain structure.
This raises topological issues that can be resolved by a
model invoking an orientation of the TraBNT domain
facing the cytosolic side of the inner membrane, while
the TraBCT domain would lie in the cytoplasm. This
would be consistent with TraB being only superficially
associated with the membrane, and therefore being able
to partition between the membrane and the cytoplasm.
It is also consistent with the dimeric structure proposed
here. Docking of the TrwB protein (a potential struc-
tural homolog of the C-terminal domain of VirB4 pro-
teins) within the envelope of the TraBCT provides
further structural details. Finally, the dimeric model of
TraB observed here suggests that there might be struc-
tural rearrangements required to fit the VirB4 dimeric
structure into the 14-fold symmetrical core complex
recently unravelled by the high resolution EM structure
of the VirB7-VirB9-VirB10 complex [23] and confirmed
by the subsequent crystal structure of its outer mem-
brane-inserting part [24]. Further studies will seek to
elucidate the crystal structure of a VirB4 protein and
also to visualize a complex of VirB4 bound to the core
complex.
Methods
Cloning of TraB domains and LvhB4
Cloning of the full-length traB gene (traBFL, amino acids
1-866; Figure 1), the region encoding the N-terminal
domain (traBNT, amino acids 1-442; Figure 1) and the
C-terminal domain (traBCT, amino acids 448-848; Fig-
ure 1), together with the full-length lvhB4 gene (lvhB4
amino acids 1-826; Legionella pneumophila strain JR32)
was as described in Durand et al. [15]. All four con-
structs allow the expression of N-terminally His6-tagged
recombinant proteins, referred to thereafter as TraBFL,
TraBNT, TraBCT, or LvhB4. After DNA sequencing
(MWG Biotech) to check that the sequences did not
contained any mutation, the four plasmids were trans-
formed by heat-shock in chemically competent BL21
star (DE3) cells (Invitrogen), for large scale production
of the recombinant proteins.
Production and Purification of Recombinant Proteins
E. coli strain BL21 star/DE3 (Invitrogen) containing one
of the recombinant plasmids was grown at 37°C in Ter-
rific Broth supplemented with 100 μg/ml of Ampicillin
(Sigma-Aldrich), until the culture reached an A600 nm of
1.2. Cultures were then shifted to 16°C for 1 h, before
isopropyl-b-D-thiogalactopyranoside (IPTG) was added
to a final concentration of 1 mM and growth continued
Figure 7 Localisation of the C-terminal domain of At-VirD4, in TraBCT and in LvhB4. (A) SAXS model of TraBCT dimer (transparent red
surface) superimposed with the At-VirB4-Cter atomic model (in ribbons and CPK representations). The black cross indicates the two-fold
symmetry axis of the dimeric TraBCT model. (B) SAXS model of LvhB4 monomer (transparent green surface) superimposed with the At-VirB4-Cter
atomic model (in ribbons representation); two SAXS models of LvhB4 monomer were fitted into the TraBFL SAXS model (transparent yellow
surface). The At-VirB4-Cter monomers were manually fitted into the TraBCT and LvhB4 models.
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for 15 h at 16°C. Cells were harvested by centrifugation,
resuspended in 20 mM TrisHCl (pH7.5) and store
at -20°C.
All subsequent steps were carried out at 4°C. TraBCT
and LvhB4 were purified from cytoplasmic extracts as
follow. The cells were defrosted and one tablet of Pro-
tease inhibitor cocktail EDTA free (Roche) was added,
together with 300 mM NaCl and 1 mM b-mercapto-
ethanol (bME). After cells were broken by two rounds
through an EmulsiFlex-C5 homogeniser and DNA frag-
mentation by sonication, the lysate was clarified by cen-
trifugation at 18,000 r.p.m. for 45 min in a Sorvall SS-34
rotor. The clarified lysate was loaded onto a HisTrapHP
5 ml column (GE Healthcare) equilibrated in buffer Asol
(20 mM TrisHCl/pH7.5, 300 mM NaCl, 1 mM bME)
plus 4% of buffer Bsol (20 mM TrisHCl/pH7.5, 300 mM
NaCl, 1 mM bME, 500 mM Imidazole). The column
was then washed with 100 ml of buffer Asol plus 8% buf-
fer Bsol. Finally the proteins still bound to the column
were eluted in a gradient from 4% to 100% of buffer Bsol
in 100 ml. Eluted fractions containing either TraBCT or
LvhB4 were pooled and concentrated in less than 4 ml
before being loaded onto a HiPrep 16/60 Sephacryl
S-300 HR column (Amersham) equilibrated in buffer
GFsol (20 mM Tris/HCl pH 7.5, 50 mM NaCl, 1 mM
bME). The proteins TraBCT and LvhB4 both eluted as a
single peak. Fractions under this peak were pooled.
TraBFL and TraBNT were purified from membrane
extracts as followed. The cells were defrosted and one
tablet of protease inhibitor cocktail EDTA free (Roche)
was added, together with 50 mM NaCl and 1 mM bME.
After cells were broken by two rounds through an
EmulsiFlex-C5 homogeniser and DNA fragmentation by
sonication, unbroken cells were removed by centrifuga-
tion at 14,000 r.p.m. for 10 min in a Sorvall SS-34 rotor.
Total membranes were pelleted by ultracentrifugation
(45 min at 100,000 g, 4°C) and resuspended in buffer EB
(20 mM Tris-HCl/pH 7.5, 50 mM NaCl, 1 mM bME,
1% (v/v) Triton® X-100) supplemented with one tablet
of protease inhibitor cocktail EDTA free (Roche). Mem-
brane-embedded proteins were extracted during 1 h at
4°C. The membrane extract was further clarified by
ultracentrifugation (30 min at 100 000 g, 4°C). Triton®
X-100 was only used for extraction, then it was replaced
by the hydrogenated Triton® X-100(H) (Calbiochem)
that does not absorb in UV. We further used a concen-
tration of 0.01% Triton® X-100(H) (0.16 mM) since it
was below the CMC of the detergent (0.2-0.9 mM), thus
avoiding the formation of detergent micelles. The
cleared extract was loaded onto a HisTrapHP 5 ml col-
umn (GE Healthcare) equilibrated in buffer Amb
(20 mM TrisHCl/pH7.5, 300 mM NaCl, 1 mM bME,
0.01% Triton® X-100(H)) plus 4% of buffer Bmb (20 mM
TrisHCl/pH7.5, 300 mM NaCl, 1 mM bME, 0.01%
Triton® X-100(H), 500 mM Imidazole). The column was
then washed with 100 ml of buffer Amb plus 8% buffer
Bmb. Finally the proteins still bound to the column were
eluted in a gradient from 4% to 100% of buffer Bmb in
100 ml. Eluted fractions containing either HisTraBFL or
HisTraBNT were pooled and concentrated in less than
4 ml before being loaded onto a HiPrep 16/60 Sephacryl
S-300 HR column (Amersham) equilibrated in buffer
GFmb (20 mM Tris/HCl pH 7.5, 50 mM NaCl, 1 mM
bME, 0.01% Triton® X-100(H)). The proteins TraBFL and
TraBNT both eluted as a single peak. Fractions under
this peak were pooled. Apparent molecular mass of pro-
teins eluted from the gel filtration column was deduced
from a calibration carried out with low and high mole-
cular mass calibration kits (Amersham Biosciences).
Determination of protein concentration was carried out
by either using the theoretical absorption coefficients at
280 nm, which were obtained using the program Prot-
Param on the EXPASY server (available on the World
Wide Web at http://www.expasy.ch/tools), or with the
Bio-Rad protein assay reagent (Bio-Rad).
Dynamic Light Scattering (DLS)
Dynamic light scattering experiments were performed
with a DynaPro-801 (Protein Solutions) at room tem-
perature. All samples were filtered prior to the measure-
ments (Millex syringe filters, 0.22 μm; Millipore Corp.).
Diffusion coefficients were inferred from the analysis of
the decay of the scattered intensity autocorrelation func-
tion. The hydrodynamic radius and the molecular mass
(MM) of proteins in solution were both deduced from
translational diffusion coefficients. All calculations were
performed using the software provided by the manufac-
turer (Dynamics V5.25.44).
SAXS Experiments
SAXS experiments were performed in two different
locations. TraBFL and TraBNT were analysed on beam-
line X33 [25] at EMBL-Hamburg on storage ring
DORIS III of the Deutsches Elektronen Synchrotron
(DESY) using a MAR 345 image plate detector. The
scattering patterns from solutions of TraBFL at protein
concentrations of 3, 5, 7.5, 10, and 13.5 mg/ml, and for
TraBNT at protein concentrations of 1.3, 2.1, 4.9, and
8.2 mg/ml were measured in buffer GFmb. At a sample
detector distance of 2.7 m and wavelength (l) of 1.5 Å,
the scattering vectors, q ranging from 0.0093 Å-1 to 0.50
Å-1 was covered (q = 4πsinθ/l, where 2θ is the scatter-
ing angle). According to radiation damage tests, one
frame of 2 min exposure time was recorded for every
sample. The data were normalised to the intensity of the
transmitted beam and radially averaged, and the scatter-
ing of the buffer was subtracted, as absolutely no trace
of the presence of micelles was detected from the buffer
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scattering curve. The difference curves were scaled for
protein concentration and extrapolated to yield the final
composite scattering curves. Molecular mass calibration
was made with BSA.
TraBCT and LvhB4 were analysed at the European
Synchrotron Radiation Facility (Grenoble, France) on
beamline ID02 as described previously [26]. The scatter-
ing patterns from solutions of TraBCT at protein con-
centrations of 2.1, 3.7, 4.3, 6.1, and 8.2 mg/ml, and for
LvhB4 at protein concentrations of 2, 2.9, 4.6, 6, 7.3,
and 8.9 mg/ml were measured in buffer GFsol. The
wavelength was 1.0 Å. The sample-to-detector distances
were set at 1.0 m (TraBCT) and 1.5 m (LvhB4), resulting
in scattering vectors, q ranging from 0.011Å-1 to
0.50 Å-1 and from 0.010Å-1 to 0.37 Å-1 respectively. All
experiments were performed at 20°C. Absolute calibra-
tion was made with water.
SAXS Data Evaluation
All steps for data processing were performed using the
program package PRIMUS [27]. The experimental SAXS
data for all samples were linear in a Guinier plot of the
low q region, indicating that the proteins did not
undergo aggregation. The radius of gyration RG was
derived by the Guinier approximation I(q) = I(0) exp
(-q2RG
2/3) for qRG < 1.0. The radii of gyration RG, calcu-
lated for different protein concentrations, displayed a
slight concentration dependence arising from particle
interferences in solution. Interference-free SAXS profiles
were estimated by extrapolating the measured scattering
curves to infinite dilution. The molecular masses of the
solutes were inferred from I(0) values, the forward scat-
tering intensity, which is proportional to the molecular
mass of the protein according to relationship MM ~I(0)/
c, where c is the protein concentration. The intensity I
(0) was experimentally inferred from the intercept of the
linear fit in the Guinier plot Ln[I(q)] versus q2 at low q
values (qRG < 1.0). The program GNOM [28] was used
to compute the pair-distance distribution functions, P(r).
This approach also features the maximum dimension of
the macromolecule, Dmax.
Ab Initio Modeling
The overall shapes of the entire assemblies were
restored from the experimental data using the program
GASBOR [19]. The scattering profiles were fitted on the
spectrum of each protein up to q = 0.37Å-1. GASBOR
searches a chain-compatible spatial distribution of an
exact number of dummy residues, centred on the Ca
atoms of the protein amino acid residues. We used both
symmetry operations P1 and P2 proposed by the pro-
gram GASBOR. At least 10 low resolution models
obtained from different runs were averaged using the
program DAMAVER [29] to construct the average
model representing the general structural features of
each reconstruction.
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